Categories: News

Delota Reports Record Revenue for the Fourth Quarter and Year Ended January 31, 2024

Highlights:

Vaughan, Ontario–(Newsfile Corp. – May 31, 2024) – Delota Corp. (CSE: NIC) (FSE: S62) (“Delota” or the “Company“), a leading Canadian omni-channel retailer of nicotine vape and alternative tobacco products is pleased to report it has filed its annual consolidated financial statements, management discussion and analysis, and associated certifications (collectively, the “Annual Filings“) for the fiscal year ended January 31, 2024. The Annual Filings may be accessed under the Company’s SEDAR+ profile at www.sedarplus.ca.

Cameron Wickham, CEO of Delota, commented, “I am very pleased with our fourth quarter and annual results for the year ended January 31, 2024, which includes record annual revenue of $34 million. We have expanded our 180 Smoke footprint across Ontario to 29 stores and strengthened our national e-commerce platform which together, serve over 220,000 loyalty members.” He continued, “We have a defined growth strategy, which includes organic brick-and-mortar expansion in Ontario and select provinces across Canada, as well as strategic M&A to accelerate growth. The industry is primed for consolidation, and Delota is well positioned to capitalize on that. As we continue to expand our platform, we will increase top line revenue and add to bottom line profitability. I am very proud of our team and look forward to continuing to excel in this exciting industry.”

Financial Highlights:

  • Total revenue of $34,069,680 for the year ended January 31, 2024 (“Year Ended 2024“), reflecting year-over-year (“YoY“) growth of 31% as compared to the year ended January 31, 2023

    • 40% gross profit margin for the Year Ended 2024

    • Positive Adjusted EBITDA of $235,552 for the Year Ended 2024

  • Total revenue of $10,152,051 for the three months ended January 31, 2024 (“Q4 2024“), reflecting YoY growth of 47% as compared to the three months ended January 31, 2023

    • 38% gross profit margin for Q4 2024

    • Positive Adjusted EBITDA of $331,138 for Q4 2024

  • Segmented Revenue for the Year Ended 2024:

    • Vape – B2C: $23,434,410, B2B: $6,874,734

    • Cannabis – B2C: $3,760,536

Other Highlights:

  • On April 29, 2024, the Company announced the expansion of its product portfolio with the addition of nicotine-based Siberia White Snus pouches through a partnership with GN Canada, the exclusive Canadian distributor and partner with global snus leader GN Tobacco.

  • On April 11, 2024, the Company provided a corporate update on its significant growth and progress.

  • On April 2, 2024, the Company changed its stock symbol from “LOTA” to “NIC” on the Canadian Securities Exchange. The new stock symbol is intended to better align with its mission of becoming the largest national specialty retailer of nicotine vape and alternative tobacco products.

  • On February 5, 2024, the Company completed debt settlements in the amount of $215,000 with certain creditors of the Company to preserve cash for working capital through the issuance of 1,535,715 units of the Company at a price of $0.14 per unit.

  • On December 19, 2023, the Company closed a non-brokered private placement of senior secured convertible debenture units for aggregate gross proceeds of $900,000.

  • On December 19, 2023, the Company opened a 180 Smoke Vape Store located at 103 10th Street East, Owen Sound, Ontario expanding 180 Smoke’s brick-and-mortar presence to 29 locations.

  • On September 25, 2023, the Company’s common shares commenced trading on the Frankfurt Stock Exchange under the symbol “S62”.

Select Financial Information

The following selected financial information for the years ended January 31, 2024, 2023 and 2022 are derived from the Company’s annual audited consolidated financial statements.

For the Years Ended January 31, 2024 2023 2022  
$ $ $  
Revenue 34,069,680 25,937,502 17,685,848
Net income (loss) for the year (1,992,576 ) 7,673,115 (8,844,970 )
Net earnings (loss) per share – basic and diluted (0.07 ) 0.31 (0.65 )
     
Working capital (deficit) (771,198 ) (1,533,522 ) (11,600,886 )
     
Total assets 13,735,729 14,780,382 13,405,060
Total non-current liabilities 6,565,672 6,093,425 6,816,858
Total liabilities 13,351,331 12,622,389 21,920,182
     
Capital stock 7,592,481 7,528,481 4,528,481
Warrant reserve 99,398 99,398 99,398
Contributed surplus 507,005 352,024 352,024
Accumulated deficit (7,814,486 ) (5,821,910 ) (13,495,025 )
Shareholders’ equity (deficiency) 384,398 2,157,993 (8,515,122 )

 

Adjusted EBITDA

The Company’s “Adjusted EBITDA” is a non-IFRS metric used by management that does not have any standardized meaning prescribed by IFRS and may not be fully comparable to similar measures presented by other companies. Management defines Adjusted EBITDA as the net income (loss) reported, before income taxes and other expense (income) items such as finance costs, finance income, gains and losses related to derivative liability valuations, and adjusted for share-based compensation, depreciation and amortization expenses, gains and losses related to the revaluations of its right-of-use assets and lease liabilities and foreign exchange differences.

The reconciliation of net income (loss) to Adjusted EBITDA is presented below.

For the Years Ended January 31, 2024 2023 2022  
$ $ $  
Net income (loss) for the year – as reported (1,992,576 ) 7,673,115 (8,898,117 )
Depreciation and amortization 575,431 640,904 489,072
Interest and accretion expenses 330,492 162,818 143,173
Stock-based compensation 218,981 180,663
Fair value adjustment of derivative liabilities 566,212
Gain on acquisition of 276 Ontario (8,129,171 )
Deferred tax recovery (63,777 ) (63,777 ) (53,147 )
Lease adjustments 567,395 (145,265 ) 142,822
Foreign exchange loss 33,394 7,745 7,325
Impairment 6,919,963  
Adjusted EBITDA 235,552 146,369 (1,068,246 )

 

About Delota Corp.

Delota is the largest omni-channel specialty vape retailer in Ontario with a mission of becoming the largest national specialty retailer of nicotine vape and alternative tobacco products. The Company’s growth strategy includes aggressively growing its flagship brand, 180 Smoke Vape Store, by expanding its retail footprint organically in Ontario and select provinces across Canada, strengthening its national e-commerce platform, and through strategic M&A to accelerate growth and market consolidation. The Company is committed to expanding its nicotine product assortment, enhancing customer experience, and growing its loyalty accounts, which now exceeds 220,000 members.

Investors interested in learning more about Delota can visit www.delota.com.

For further information, please contact:

Delota Corp.

Julia Becker
Capital Markets
T: (604) 785-0850
E: ir@delota.com

Cameron Wickham
Executive Vice Chair and CEO
T: (905) 330-1602
E: info@delota.com

Cautionary Statements

This press release contains “forward-looking statements or information”. Forward-looking statements can be identified by words such as: anticipate, intend, plan, goal, seek, believe, project, estimate, expect, strategy, future, likely, may, should, will and similar references to future periods. Examples of forward-looking statements in this press release include statements made regarding information about future plans, expectations and objectives of the Company overall.

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. The Company may not actually achieve its plans, projections, or expectations. The forward-looking statements and information are based on certain key expectations and assumptions made by the Company. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: the adequacy of our cash flow and earnings, the availability of future financing and/or credit, developments and changes in laws and regulations, consumer sentiment towards the Company’s products, failure of counterparties to perform their contractual obligations, government regulations, competition, loss of key employees and consultants, and general economic, market or business conditions, the impact of technology and social changes on the products and industry, as well as those risk factors discussed or referred to in disclosure documents filed by the Company with the securities regulatory authorities in certain provinces of Canada and available at www.sedarplus.ca. Given these risks, uncertainties and assumptions, you should not place undue reliance on these forward-looking statements.

Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. Except as required by applicable securities laws, we undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

The CSE has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.


1 Based on number of retail stores in Ontario.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/211244

Staff

Recent Posts

deCODE genetics: The rate, nature and transmission of mitochondrial DNA mutations in humans

A new study from deCODE genetics uses pedigrees and sequence data from 64,806 Icelanders to…

2 hours ago

Hospital PMI® at 58.4%; May 2024 Hospital ISM® Report On Business®

TEMPE, Ariz., June 7, 2024 /PRNewswire/ -- Economic activity in the hospital subsector grew in May for…

2 hours ago

Neogen® Releases CelluSmart Technology for Biofuel Industry

LANSING, Mich., June 7, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG), an innovative leader in…

2 hours ago

IONETIX Produces First Batch of Actinium-225

LANSING, Mich., June 7, 2024 /PRNewswire/ -- IONETIX, a leading cyclotron technology innovator, isotope producer,…

2 hours ago

Pair Eyewear Expands Global Footprint With Direct-To-Consumer Expansion Into The UK And Australia

On a mission to bring joy into the often-overlooked optical industry, Pair Eyewear also announces…

2 hours ago

Edgepark launches new e-Ordering platform for healthcare providers

Edgepark opens the first ostomy storefront available nationwide through Parachute Health TWINSBURG, Ohio, June 7,…

2 hours ago